Literature DB >> 16219626

Deletions in the polyAlanine-containing transcription factor FOXL2 lead to intranuclear aggregation.

Lara Moumné1, Marc Fellous, Reiner A Veitia.   

Abstract

Mutations of FOXL2, a gene encoding a forkhead transcription factor, have been shown to cause the blepharophimosis-ptosis-epicanthus inversus syndrome. This genetic disorder is characterized by eyelid and craniofacial abnormalities associated or not with premature ovarian failure. We have previously shown that mutant FOXL2 with an expanded polyAlanine (polyAla) tract forms large aggregates both in the nucleus and in the cytoplasm of transfected cells, whereas the wild-type protein localizes in the nucleus in a rather diffuse manner. Premature stop codons in FOXL2 have been considered so far as null alleles. However, we demonstrate here that such nonsense mutations may lead to the production of N-terminally truncated proteins by re-initiation of translation downstream of the stop codon. Surprisingly, the truncated proteins strongly aggregate in the nucleus, partially localize in the cytoplasm and retain a fraction of the wild-type protein. We also show that a complete deletion of the polyAla tract of FOXL2 induces a significant intranuclear aggregation. Our results enlarge the spectrum of mutations inducing FOXL2 aggregation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219626     DOI: 10.1093/hmg/ddi383

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

1.  Expansion of polyalanine tracts in the QA domain may play a critical role in the clavicular development of cleidocranial dysplasia.

Authors:  Li-Zheng Wu; Xin-Yue Xu; Ying-Feng Liu; Xin Ge; Xiao-Jing Wang
Journal:  J Genet       Date:  2015-09       Impact factor: 1.166

2.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics.

Authors:  Frank Batista; Daniel Vaiman; Jean Dausset; Marc Fellous; Reiner A Veitia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

3.  FOXL2 mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.

Authors:  Juan Wang; Jinling Liu; Qingjiong Zhang
Journal:  Mol Vis       Date:  2007-01-26       Impact factor: 2.367

4.  Mechanism of escape from nonsense-mediated mRNA decay of human beta-globin transcripts with nonsense mutations in the first exon.

Authors:  Gabriele Neu-Yilik; Beate Amthor; Niels H Gehring; Sharif Bahri; Helena Paidassi; Matthias W Hentze; Andreas E Kulozik
Journal:  RNA       Date:  2011-03-09       Impact factor: 4.942

5.  Key Role of Amino Acid Repeat Expansions in the Functional Diversification of Duplicated Transcription Factors.

Authors:  Núria Radó-Trilla; Krisztina Arató; Cinta Pegueroles; Alicia Raya; Susana de la Luna; M Mar Albà
Journal:  Mol Biol Evol       Date:  2015-04-29       Impact factor: 16.240

6.  Novel FOXL2 mutations in two Chinese families with blepharophimosis-ptosis-epicanthus inversus syndrome.

Authors:  Min Xue; Jie Zheng; Qing Zhou; J Fielding Hejtmancik; Yuan Wang; Shouling Li
Journal:  BMC Med Genet       Date:  2015-09-01       Impact factor: 2.103

7.  Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency.

Authors:  Xiao-Wen Yang; Wen-Bin He; Fei Gong; Wen Li; Xiu-Rong Li; Chang-Gao Zhong; Guang-Xiu Lu; Ge Lin; Juan Du; Yue-Qiu Tan
Journal:  Mol Genet Genomic Med       Date:  2018-01-29       Impact factor: 2.183

Review 8.  The Genetic and Clinical Features of FOXL2-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome.

Authors:  Cécile Méjécase; Chandni Nigam; Mariya Moosajee; John C Bladen
Journal:  Genes (Basel)       Date:  2021-03-04       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.